CN101389594B - 金刚烷基胺的制备方法 - Google Patents
金刚烷基胺的制备方法 Download PDFInfo
- Publication number
- CN101389594B CN101389594B CN2007800060848A CN200780006084A CN101389594B CN 101389594 B CN101389594 B CN 101389594B CN 2007800060848 A CN2007800060848 A CN 2007800060848A CN 200780006084 A CN200780006084 A CN 200780006084A CN 101389594 B CN101389594 B CN 101389594B
- Authority
- CN
- China
- Prior art keywords
- acid
- formula
- adamantylamine
- compound
- salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/02—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
- C07C233/04—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C233/06—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C209/00—Preparation of compounds containing amino groups bound to a carbon skeleton
- C07C209/62—Preparation of compounds containing amino groups bound to a carbon skeleton by cleaving carbon-to-nitrogen, sulfur-to-nitrogen, or phosphorus-to-nitrogen bonds, e.g. hydrolysis of amides, N-dealkylation of amines or quaternary ammonium compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C335/00—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C335/30—Isothioureas
- C07C335/32—Isothioureas having sulfur atoms of isothiourea groups bound to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/56—Ring systems containing bridged rings
- C07C2603/58—Ring systems containing bridged rings containing three rings
- C07C2603/70—Ring systems containing bridged rings containing three rings containing only six-membered rings
- C07C2603/74—Adamantanes
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Hospice & Palliative Care (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Psychiatry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP06003477A EP1820792B1 (en) | 2006-02-21 | 2006-02-21 | Process for the preparation of adamantanamines |
| EP06003477 | 2006-02-21 | ||
| EP0600347.7 | 2006-02-21 | ||
| PCT/EP2007/001440 WO2007096124A1 (en) | 2006-02-21 | 2007-02-20 | Process for the preparation of adamantanamines |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101389594A CN101389594A (zh) | 2009-03-18 |
| CN101389594B true CN101389594B (zh) | 2013-06-12 |
Family
ID=36754153
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2007800060848A Expired - Fee Related CN101389594B (zh) | 2006-02-21 | 2007-02-20 | 金刚烷基胺的制备方法 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20090082596A1 (https=) |
| EP (1) | EP1820792B1 (https=) |
| JP (1) | JP5235683B2 (https=) |
| CN (1) | CN101389594B (https=) |
| AT (1) | ATE541827T1 (https=) |
| AU (1) | AU2007218140B2 (https=) |
| CA (1) | CA2640127C (https=) |
| DK (1) | DK1820792T3 (https=) |
| ES (1) | ES2379181T3 (https=) |
| PL (1) | PL1820792T3 (https=) |
| PT (1) | PT1820792E (https=) |
| SI (1) | SI1820792T1 (https=) |
| WO (1) | WO2007096124A1 (https=) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1908748A1 (en) | 2006-10-05 | 2008-04-09 | Krka | Process for the preparation of memantine and its hydrochloric acid salt form |
| WO2010007351A1 (en) * | 2008-07-14 | 2010-01-21 | Cipla Limited | Process for the preparation of memantine and its salts and intermediate for use therein |
| CN101560157B (zh) * | 2009-06-02 | 2013-09-18 | 王彦明 | 盐酸金刚烷胺生产工艺及其专用设备 |
| CN102070463A (zh) * | 2009-06-11 | 2011-05-25 | 辽宁利锋科技开发有限公司 | 具有金刚烷结构药物美金刚胺及其衍生物和类似物抗肿瘤新适应症的应用 |
| JP5749260B2 (ja) * | 2009-06-29 | 2015-07-15 | メルツ・ファルマ・ゲーエムベーハー・ウント・コ・カーゲーアーアー | ネラメキサンの製造方法 |
| HRP20130485T1 (en) * | 2009-06-29 | 2013-06-30 | Merz Pharma Gmbh & Co. Kgaa | Method of preparing 1-amino-1,3,3,5,5-pentamethylcyclohexane |
| HRP20130486T1 (en) * | 2009-06-29 | 2013-06-30 | Merz Pharma Gmbh & Co. Kgaa | Method of preparing neramexane |
| EP2448911A1 (en) * | 2009-06-29 | 2012-05-09 | Merz Pharma GmbH & Co. KGaA | Method of preparing 1-chloroacetamido-1,3,3,5,5-pentamethylcyclohexane |
| CN101993377A (zh) * | 2009-08-07 | 2011-03-30 | 出光兴产株式会社 | 具有金刚烷骨架的胺类和季铵盐的制造方法 |
| CN104936942A (zh) * | 2013-01-23 | 2015-09-23 | 三菱瓦斯化学株式会社 | 美金刚胺的制造工艺 |
| CN103483205B (zh) * | 2013-10-12 | 2015-02-04 | 合肥久诺医药科技有限公司 | 一种高纯度盐酸美金刚的制备方法 |
| CN103524353B (zh) * | 2013-10-12 | 2015-03-25 | 合肥久诺医药科技有限公司 | 一种高纯度盐酸美金刚的制备方法 |
| CN104693039B (zh) * | 2015-01-06 | 2016-11-16 | 中山大学 | 一种金刚烷胺类衍生物及其制备方法和应用 |
| CN105399636A (zh) * | 2015-12-18 | 2016-03-16 | 天津民祥生物医药股份有限公司 | 一种利用盐酸金刚烷胺制备金刚烷胺游离胺的工艺 |
| CN117843492A (zh) * | 2023-12-04 | 2024-04-09 | 四川众邦新材料股份有限公司 | 金刚烷胺生产中的产物分离提取方法 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3391142A (en) | 1966-02-09 | 1968-07-02 | Lilly Co Eli | Adamantyl secondary amines |
| ES413944A1 (es) * | 1972-04-20 | 1976-06-01 | Merz & Co | Procedimiento para la preparacion de compuestos de adamen- tano trisustituidos en las posiciones 1,3,5. |
| DE2318461A1 (de) | 1973-04-12 | 1974-10-31 | Merz & Co | Verfahren zur herstellung von 1,3,5trisubstituierten adamanta-verbindungen |
| SU805609A1 (ru) * | 1979-10-12 | 1981-09-30 | Предприятие П/Я В-2343 | S-(1-адамантилкарбпмоилметил) изотиуроний хлорид,обладающий антивирусной активностью |
| ES2059602T3 (es) | 1989-04-14 | 1994-11-16 | Merz & Co Gmbh & Co | Uso de derivados de adamantano para la prevencion y tratamiento de isquemia cerebral. |
| US5948820A (en) * | 1994-08-22 | 1999-09-07 | Yoshitomi Pharmaceutical Industries, Ltd. | Benzene compound and pharmaceutical use thereof |
| CZ288445B6 (en) | 1996-06-20 | 2001-06-13 | Lachema Np | Process for preparing hydrochloride of 5-amino-1,3-dimethyltricyclo(3,3,1,1 3,7 )decane |
| GB0001093D0 (en) | 2000-01-19 | 2000-03-08 | F2 Chemicals Ltd | Selective nitrogen functionalisation of organic compounds |
| GB0018272D0 (en) * | 2000-07-25 | 2000-09-13 | Vernalis Research Limited | Chemical compounds IV |
| JP4118555B2 (ja) * | 2001-12-13 | 2008-07-16 | 株式会社トクヤマ | N−(アダマンチル)アミド化合物の製造方法 |
| RU2246482C2 (ru) | 2002-12-25 | 2005-02-20 | ООО "Циклан" | Способ получения гидрохлорида 1-амино-3,5-диметиладамантана |
| CN1240668C (zh) | 2003-09-10 | 2006-02-08 | 上海医药工业研究院 | 一种新的盐酸美金刚制备方法 |
| WO2005062724A2 (en) * | 2003-12-31 | 2005-07-14 | Sun Pharmaceutical Industries Limited | Novel process for the preparation of aminoadamantane derivatives |
| EP1708707A1 (en) * | 2004-01-22 | 2006-10-11 | Neurosearch A/S | Pharmaceutical composition comprising a monoamine neurotransmitter re-uptake inhibitor and an n-methyl-d-aspartate (nmda) receptors antagonist |
| US7456224B2 (en) * | 2004-04-05 | 2008-11-25 | Forest Laboratories Holdings, Ltd. | Method for treating autism |
| EP1879849A1 (en) * | 2005-05-11 | 2008-01-23 | Dr. Reddy's Laboratories, Inc. | Process for preparing memantine |
-
2006
- 2006-02-21 AT AT06003477T patent/ATE541827T1/de active
- 2006-02-21 ES ES06003477T patent/ES2379181T3/es not_active Expired - Lifetime
- 2006-02-21 EP EP06003477A patent/EP1820792B1/en not_active Expired - Lifetime
- 2006-02-21 DK DK06003477.4T patent/DK1820792T3/da active
- 2006-02-21 SI SI200631279T patent/SI1820792T1/sl unknown
- 2006-02-21 PT PT06003477T patent/PT1820792E/pt unknown
- 2006-02-21 PL PL06003477T patent/PL1820792T3/pl unknown
-
2007
- 2007-02-20 CA CA2640127A patent/CA2640127C/en not_active Expired - Fee Related
- 2007-02-20 CN CN2007800060848A patent/CN101389594B/zh not_active Expired - Fee Related
- 2007-02-20 AU AU2007218140A patent/AU2007218140B2/en not_active Ceased
- 2007-02-20 WO PCT/EP2007/001440 patent/WO2007096124A1/en not_active Ceased
- 2007-02-20 JP JP2008555684A patent/JP5235683B2/ja active Active
- 2007-02-20 US US12/224,147 patent/US20090082596A1/en not_active Abandoned
Non-Patent Citations (1)
| Title |
|---|
| Aigars Jirgensons等.A Practical Synthesis of tert-Alkylamines via the Ritter Reaction with Chloroacetonitrile.《Synthesis》.2000,(第12期), * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101389594A (zh) | 2009-03-18 |
| EP1820792A1 (en) | 2007-08-22 |
| ES2379181T3 (es) | 2012-04-23 |
| AU2007218140B2 (en) | 2010-08-19 |
| AU2007218140A1 (en) | 2007-08-30 |
| JP5235683B2 (ja) | 2013-07-10 |
| EP1820792B1 (en) | 2012-01-18 |
| CA2640127A1 (en) | 2007-08-30 |
| WO2007096124A1 (en) | 2007-08-30 |
| CA2640127C (en) | 2015-08-11 |
| US20090082596A1 (en) | 2009-03-26 |
| PT1820792E (pt) | 2012-04-10 |
| ATE541827T1 (de) | 2012-02-15 |
| PL1820792T3 (pl) | 2012-06-29 |
| JP2009527517A (ja) | 2009-07-30 |
| DK1820792T3 (da) | 2012-04-10 |
| SI1820792T1 (sl) | 2012-04-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101389594B (zh) | 金刚烷基胺的制备方法 | |
| CN106414436A (zh) | 制备n-[(3-氨基氧杂环丁烷-3-基)甲基]-2-(1, 1-二氧代-3, 5-二氢-1, 4-苯并硫杂氮杂环庚三烯-4-基)-6-甲基-喹唑啉-4-胺的方法 | |
| WO1999001420A1 (en) | Process for the preparation of 2-aminomalonic acid derivatives and intermediates used in the process | |
| KR101532570B1 (ko) | 벤즈아미드 화합물의 합성에 유용한 화합물 | |
| KR20000029649A (ko) | 5-[아세틸(2,3-디히드록시프로필)아미노]-n,n'-비스(2,3-디히드록시프로필)-2,4,6-트리요오도-1,3-벤젠디카르복스아미드의제조방법 | |
| US20060173215A1 (en) | Process for the preparation of 1-amino-3,5-dimethyladamantane hydrochloride | |
| CN101993377A (zh) | 具有金刚烷骨架的胺类和季铵盐的制造方法 | |
| CN102307845B (zh) | 盐酸西那卡塞特的制备方法 | |
| CN107922326A (zh) | 阿普斯特的制备方法及其中间体 | |
| US20110124899A1 (en) | Method for preparing combretastatin | |
| US9493473B2 (en) | Processes for making ponatinib and intermediates thereof | |
| CN104918912B (zh) | 2‑氨基‑4,6‑二甲氧基苯甲酰胺和其他苯甲酰胺化合物的合成方法 | |
| US20120095256A1 (en) | Process for producing threo-3-(3,4-dihydroxyphenyl)-l-serine | |
| JP2005501881A (ja) | α−ジフルオロメチルオルニチン(DFMO)の製造方法 | |
| JP4721518B2 (ja) | 5−アミノ−イソフタルアミドの製造方法 | |
| CN103664577B (zh) | 一种西那卡塞中间体的制备方法 | |
| HK1129365A (en) | Process for the preparation of adamantanamines | |
| CN110878097A (zh) | 菲格替尼的制备方法 | |
| CN101102996A (zh) | 制备1-氨基-3,5-二甲基金刚烷盐酸盐的方法 | |
| JP3481242B2 (ja) | C−置換されたジエチレントリアミンの製法 | |
| CN107531654A (zh) | 制备二羧酸化合物的方法 | |
| HK40106397A (zh) | 化合物或其药学上允许的盐的制造方法 | |
| JPH0665166A (ja) | α−(m−ニトロフェニル)アルキルアミンとα−(p−ニトロフェニル)アルキルアミンの分離方法、およびこれを用いたα−(m−アミノフェニル)アルキルアミンおよびα−(p−アミノフェニル)アルキルアミン類の製造方法 | |
| JP2004026676A (ja) | ハロゲノ−4−ジヒドロキシメチルピリジン、その製造法及びそれを用いたハロゲノ−4−ピリジンカルバルデヒドの製造法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| CI01 | Publication of corrected invention patent application |
Correction item: Priority Correct: 2006.2.21 EP 06003477 False: 2006.2.21 EP 0600347.7 Number: 11 Page: 1006 Volume: 25 |
|
| CI02 | Correction of invention patent application |
Correction item: Priority Correct: 2006.2.21 EP 06003477 False: 2006.2.21 EP 0600347.7 Number: 11 Page: The title page Volume: 25 |
|
| ERR | Gazette correction |
Free format text: CORRECT: PRIORITY; FROM: 2006.2.21 EP 0600347.7 TO: 2006.2.21 EP 06003477 |
|
| REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1129365 Country of ref document: HK |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| REG | Reference to a national code |
Ref country code: HK Ref legal event code: WD Ref document number: 1129365 Country of ref document: HK |
|
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20130612 Termination date: 20210220 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |